Unexplained intrauterine fetal death is accompanied by activation of complement

Journal of Perinatal Medicine

Volumn 33, Issue 4, 2005, Pages 296-305

  Richani, Karina ^a,b,c   Romero, Roberto ^a,b,e   Soto, Eleazar ^a,b,c   Espinoza, Jimmy ^a,b,c   Nien, Jyh Kae ^a,b   Chaiworapongsa, Tinnakorn ^a,b,c   Refuerzo, Jerrie ^c   Blackwell, Sean ^c   Edwin, Samuel S ^a,b   Santolaya Forgas, Joaquin ^a,b,c   Mazor, Moshe ^d  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^e HUTZEL HOSPITAL   (United States)

Author keywords

Anaphylatoxins; C3a; C4a; C5a; Complement system; Intrauterine fetal death; Preeclampsia; Pregnancy

Indexed keywords

COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C4A; COMPLEMENT COMPONENT C5A;

ADOLESCENT; ADULT; ARTICLE; CHROMOSOME ABERRATION; COMPLEMENT ACTIVATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FETUS DEATH; FETUS MALFORMATION; HUMAN; MAJOR CLINICAL STUDY; MATERNAL PLASMA; PREECLAMPSIA; PREGNANT WOMAN; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; STATISTICAL PARAMETERS; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; COMPLEMENT ACTIVATION; COMPLEMENT C3A; COMPLEMENT C4A; COMPLEMENT C5A; CROSS-SECTIONAL STUDIES; FEMALE; FETAL DEATH; FETUS; HUMANS; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PREGNANCY TRIMESTER, THIRD; STATISTICS, NONPARAMETRIC;

EID: 23944507561     PISSN: 03005577     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPM.2005.052     Document Type: Article

References (101)

1. Ahmed AE, JB Peter: Clinical utility of complement assessment. Clin Diagn Lab Immunol 2 (1995) 509
2. Albrecht EA, AM Chinnaiyan, S Varambally, C Kumar-Sinha, TR Barrette, JV Sarma, PA Ward: C5a-induced gene expression in human umbilical vein endothelial cells. Am J Pathol 164 (2004) 849
3. Alonso A, I Soto, MF Urgelles, JR Corte, MJ Rodriguez, CR Pinto: Acquired and inherited thrombophilia in women with unexplained fetal losses. Am J Obstet Gynecol 187 (2002) 1337
4. Aluvihare VR, M Kallikourdis, AG Betz: Regulatory T cells mediate maternal tolerance to the fetus. Nat Immunol 5 (2004) 266
5. Blackwell S, R Romero, T Chaiworapongsa, J Refuerzo, MT Gervasi, J Yoshimatsu, J Espinoza, S Berman, BH Yoon: Unexplained fetal death is associated with changes in the adaptive limb of the maternal immune response consistent with prior antigenic exposure. J Matern Fetal Neonatal Med 14 (2003) 241
6. Brady K, P Duff, FE Harlass, S Reid: Role of amniotic fluid cytogenetic analysis in the evaluation of recent fetal death. Am J Perinatol 8 (1991) 68
7. Carroll MC: The complement system in regulation of adaptive immunity. Nat Immunol 5 (2004) 981
8. Cochrane CG, HJ Muller-Eberhard: The derivation of two distinct anaphylatoxin activities from the third and fifth components of human complement. J Exp Med 127 (1968) 371
9. Cunningham DS, JR Tichenor, Jr: Decay-accelerating factor protects human trophoblast from complement-mediated attack. Clin Immunol Immunopathol 74 (1995) 156
10. Czermak BJ, V Sarma, CL Pierson, RL Warner, M Huber-Lang, NM Bless, H Schmal, HP Friedl, PA Ward: Protective effects of C5a blockade in sepsis. Nat Med 5 (1999) 788
11. Daffern PJ, PH Pfeifer, JA Ember, TE Hugli: C3a is a chemotaxin for human eosinophils but not for neutrophils. I. C3a stimulation of neutrophils is secondary to eosinophil activation. J Exp Med 181 (1995) 2119
12. Davies M: An ELISA for the detection of maternal antitrophoblast antibodies in human pregnancy. J Immunol Methods 77 (1985) 109
13. Davies M, CM Browne: Anti-trophoblast antibody responses during normal human pregnancy. J Reprod Immunol 7 (1985) 285
14. Dias DS, IH Lepow: Complement as a mediator of inflammation. II. Biological properties of anaphylatoxin prepared with purified components of human complement. J Exp Med 125 (1967) 921
15. Ehrengruber MU, T Geiser, DA Deranleau: Activation of human neutrophils by C3a and C5A. Comparison of the effects on shape changes, chemotaxis, secretion, and respiratory burst. FEBS Lett 346 (1994) 181
16. Elsner J, M Oppermann, W Czech, G Dobos, E Schopf, J Norgauer, A Kapp: C3a activates reactive oxygen radical species production and intracellular calcium transients in human eosinophils. Eur J Immunol 24 (1994) 518
17. Elsner J, M Oppermann, W Czech, A Kapp: C3a activates the respiratory burst in human polymorphonuclear neutrophilic leukocytes via pertussis toxin-sensitive G-proteins. Blood 83 (1994) 3324
18. Ember JA, MA Jagels, TE Hugli: Characterization of Complement Anaphylatoxins and Their Biological Responses. In: Volanakis JE, MM Frank: The Human Complement System in Health and Disease. Marcel Dekker, INC., New York 1998
19. Ember JA, SD Sanderson, TE Hugli, EL Morgan: Induction of interleukin-8 synthesis from monocytes by human C5a anaphylatoxin. Am J Pathol 144 (1994) 393
20. Faulk WP, R Jarret, M Keane, PM Johnson, RJ Boackle: Immunological studies of human placentae: complement components in immature and mature chorionic villi. Clin Exp Immunol 40 (1980) 299
21. Fernandez HN, TE Hugli: Primary structural analysis of the polypeptide portion of human C5a anaphylatoxin. Polypeptide sequence determination and assignment of the oligosaccharide attachment site in C5a. J Biol Chem 253 (1978) 6955
22. Foreman KE, AA Vaporciyan, BK Bonish, ML Jones, KJ Johnson, MM Glovsky, SM Eddy, PA Ward: C5a-induced expression of P-selectin in endothelial cells. J Clin Invest 94 (1994) 1147
23. Gasque P: Complement: a unique innate immune sensor for danger signals. Mol Immunol 41 (2004) 1089
24. Gibbs RS: The origins of stillbirth: infectious diseases. Semin Perinatol 26 (2002) 75
25. Girardi G, J Berman, P Redecha, L Spruce, JM Thurman, D Kraus, TJ Hollmann, P Casali, MC Caroll, RA Wetsel, JD Lambris, VM Holers, JE Salmon: Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome. J Clin Invest 112 (2003) 1644
26. Girardi G, P Redecha, JE Salmon: Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation. Nat Med 10 (2004) 1222
27. Girardi G, JB Salmon: The role of complement in pregnancy and fetal loss. Autoimmunity 36 (2003) 19
28. Goldenberg RL, C Thompson: The infectious origins of stillbirth. Am J Obstet Gynecol 189 (2003) 861
29. Goldstein IM, D Roos, HB Kaplan, G Weissmann: Complement and immunoglobulins stimulate superoxide production by human leukocytes independently of phagocytosis. J Clin Invest 56 (1975) 1155
30. Gorbet MB, MV Sefton: Biomaterial-associated thrombosis: roles of coagulation factors, complement, platelets and leukocytes. Biomaterials 25 (2004) 5681
31. Gorski JP, TE Hugli, HJ Muller-Eberhard: C4a: the third anaphylatoxin of the human complement system. Proc Natl Acad Sci USA 76 (1979) 5299
32. Grant EP, D Picarella, T Burwell, T Delaney, A Croci, N Avitahl, AA Humbles, JC Gutierrez-Ramos, M Briskin, C Gerard, AJ Coyle: Essential role for the C5a receptor in regulating the effector phase of synovial infiltration and joint destruction in experimental arthritis. J Exp Med 196 (2002) 1461
33. Greer IA: Thrombophilia: implications for pregnancy outcome. Thromb Res 109 (2003) 73
34. Haeger M, M Unander, A Bengtsson: Complement activation in relation to development of preeclampsia. Obstet Gynecol 78 (1991) 46
35. Haeger M, M Unander, B Norder-Hansson, M Tylman, A Bengtsson: Complement, neutrophil, and macrophage activation in women with severe preeclampsia and the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Obstet Gynecol 79 (1992) 19
36. Hartmann K, BM Henz, S Kruger-Krasagakes, J Kohl, R Burger, S Guhl, I Haase, U Lippert, T Zuberbier: C3a and C5a stimulate chemotaxis of human mast cells. Blood 89 (1997) 2863
37. Hill JA, K Polgar, DJ Anderson: T-helper 1-type immunity to trophoblast in women with recurrent spontaneous abortion. JAMA 273 (1995) 1933
38. Holers VM, G Girardi, L Mo, JM Guthridge, H Molina, SS Pierangeli, R Espinola, LE Xiaowei, D Mao, CG Vialpando, JE Salmon: Complement C3 activation is required for antiphospholipid antibody-induced fetal loss. J Exp Med 195 (2002) 211
39. Holmes CH, KL Simpson, H Okada, N Okada, SD Wainwright, DF Purcell, JM Houlihan: Complement regulatory proteins at the feto-maternal interface during human placental development: distribution of CD59 by comparison with membrane cofactor protein (CD46) and decay accelerating factor (CD55). Eur J Immunol 22 (1992) 1579
40. Holmes CH, KL Simpson, SD Wainwright, CG Tate, JM Houlihan, IH Sawyer, IP Rogers, FA Spring, DJ Anstee, MJ Tanner: Preferential expression of the complement regulatory protein decay accelerating factor at the fetomaternal interface during human pregnancy. J Immunol 144 (1990) 3099
41. Howarth ES, JC Konje, KA Healey, DP Duckett, IW Scudamore, DJ Taylor: Invasive testing for the karyotyping of mid-trimester intrauterine fetal death (IUFD): a pilot study. Prenat Diagn 22 (2002) 453
42. Hsi BL, JS Hunt, JP Atkinson: Differential expression of complement regulatory proteins on subpopulations of human trophoblast cells. J Reprod Immunol 19 (1991) 209
43. Huber-Lang M, EM Younkin, JV Sarma, N Riedemann, SR McGuire, KT Lu, R Kunkel, JG Younger, FS Zetoune, PA Ward: Generation of C5a by phagocytic cells. Am J Pathol 161 (2002) 1849
44. Ikeda K, K Nagasawa, T Horiuchi, T Tsuru, H Nishizaka, Y Niho: C5a induces tissue factor activity on endothelial cells. Thromb Haemost 77 (1997) 394
45. Jagels MA, PJ Daffern, TE Hugli: C3a and C5a enhance granulocyte adhesion to endothelial and epithelial cell monolayers: epithelial and endothelial priming is required for C3a-induced eosinophil adhesion. Immunopharmacology 46 (2000) 209
46. Kamimura S, K Eguchi, M Yonezawa, K Sekiba: Localization and developmental change of indoleamine 2,3-dioxygenase activity in the human placenta. Acta Med Okayama 45 (1991) 135
47. Kazatchkine MD, DT Fearon, DD Metcalfe, RD Rosenberg, KF Austen: Structural determinants of the capacity of heparin to inhibit the formation of the human amplification C3 convertase. J Clin Invest 67 (1981) 223
48. Laudes IJ, JC Chu, S Sikranth, M Huber-Lang, RF Guo, N Riedemann, JV Sarma, AH Schmaier, PA Ward: Anti-c5a ameliorates coagulation/fibrinolytic protein changes in a rat model of sepsis. Am J Pathol 160 (2002) 1867
49. Lin H, TR Mosmann, L Guilbert, S Tuntipopipat, TG Wegmann: Synthesis of T helper 2-type cytokines at the maternal-fetal interface. J Immunol 151 (1993) 4562
50. Mao D, X Wu, C Deppong, LD Friend, G Dolecki, DM Nelson, H Molina: Negligible role of antibodies and C5 in pregnancy loss associated exclusively with C3-dependent mechanisms through complement alternative pathway. Immunity 19 (2003) 813
51. Marzi M, A Vigano, D Trabattoni, ML Villa, A Salvaggio, E Clerici, M Clerici: Characterization of type 1 and type 2 cytokine production profile in physiologic and pathologic human pregnancy. Clin Exp Immunol 106 (1996) 127
52. Medzhitov R, CA Janeway, Jr: Decoding the patterns of self and nonself by the innate immune system. Science 296 (2002) 298
53. Mellor AL, J Sivakumar, P Chandler, K Smith, H Molina, D Mao, DH Munn: Prevention of T cell-driven complement activation and inflammation by tryptophan catabolism during pregnancy. Nat Immunol 2 (2001) 64
54. Molina H: Complement and immunity. Rheum Dis Clin North Am 30 (2004) 1
55. Munn DH, M Zhou, JT Attwood, I Bondarev, SJ Conway, B Marshall, C Brown, AL Mellor: Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 281 (1998) 1191
56. Naccasha N, MT Gervasi, T Chaiworapongsa, S Berman, BH Yoon, E Maymon, R Romero: Phenotypic and metabolic characteristics of monocytes and granulocytes in normal pregnancy and maternal infection. Am J Obstet Gynecol 185 (2001) 1118
57. Ninomiya H, Y Kawashima, T Nagasawa: Inhibition of complement-mediated haemolysis in paroxysmal nocturnal haemoglobinuria by heparin or low-molecular weight heparin. Br J Haematol 109 (2000) 875
58. Okusawa S, CA Dinarello, KB Yancey, S Endres, TJ Lawley, MM Frank, JF Burke, JA Gelfand: C5a induction of human interleukin 1. Synergistic effect with endotoxin or interferon-gamma. J Immunol 139 (1987) 2635
59. Okusawa S, KB Yancey, JW van der Meer, S Endres, G Lonnemann, K Hefter, MM Frank, JF Burke, CA Dinarello, JA Gelfand: C5a stimulates secretion of tumor necrosis factor from human mononuclear cells in vitro. Comparison with secretion of interleukin 1 beta and interleukin 1 alpha. J Exp Med 168 (1988) 443
60. Oshiro BT, RM Silver, JR Scott, H Yu, DW Branch: Antiphospholipid antibodies and fetal death. Obstet Gynecol 87 (1996) 489
61. Perianayagam MC, VS Balakrishnan, AJ King, BJ Pereira, BL Jaber: C5a delays apoptosis of human neutrophils by a phosphatidylinositol 3-kinase-signaling pathway. Kidney Int 61 (2002) 456
62. Preston FE, FR Rosendaal, ID Walker, E Briet, E Berntorp, J Conard, J Fontcuberta, M Makris, G Mariani, W Note-boom, I Pabinger, C Legnani, I Scharrer, S Schulman, FJ van der Meer: Increased fetal loss in women with heritable thrombophilia. Lancet 348 (1996) 913
63. Rey E, SR Kahn, M David, I Shrier: Thrombophilic disorders and fetal loss: a meta-analysis. Lancet 361 (2003) 901
64. Richani K, E Soto, J Espinoza, J Nien, T Chaiworapongsa, S Edwin, M Mazor, R Romero: Normal pregnancy is characterized by systemic complement activation of the complement system. Am J Obstet Gynecol 191 (2004) S139 (abstract)
65. Richani K, E Soto, R Romero, J Espinoza, T Chaiworapongsa, J Nien, S Edwin, Y Kim, J Hong, L Goncalves, M Mazor: Preeclampsia and SGA differ in the maternal plasma complement split products profile. J Soc Gynecol Investig 12 (2005) 148A (abstract)
66. Riedemann NC, RF Guo, TJ Hollmann, H Gao, TA Neff, JS Reuben, CL Speyer, JV Sarma, RA Wetsel, FS Zetoune, PA Ward: Regulatory role of C5a in LPS-induced IL-6 production by neutrophils during sepsis. FASEB J 18 (2004) 370
67. Saal HM, J Rodis, PJ Weinbaum, R DiMaggio, TM Landrey: Cytogenetic evaluation of fetal death: the role of amniocentesis. Obstet Gynecol 70 (1987) 601
68. Sacks G, Sargent I, Redman C. An innate view of human pregnancy. Immunol Today 20 (1999) 114
69. Salmon JE, G Girardi, VM Holers: Activation of complement mediates antiphospholipid antibody-induced pregnancy loss. Lupus 12 (2003) 535
70. Sarig G, JS Younis, R Hoffman, N Lanir, Z Blumenfeld, B Brenner: Thrombophilia is common in women with idiopathic pregnancy loss and is associated with late pregnancy wastage. Fertil Steril 77 (2002) 342
71. Schindler R, JA Gelfand, CA Dinarello: Recombinant C5a stimulates transcription rather than translation of interleukin-1 (IL-1) and tumor necrosis factor: translational signal provided by lipopolysaccharide or IL-1 itself. Blood 76 (1990) 1631
72. Scholz W, MR McClurg, GJ Cardenas, M Smith, DJ Noonan, TE Hugli, EL Morgan: C5a-mediated release of interleukin 6 by human monocytes. Clin Immunol Immunopathol 57 (1990) 297
73. Schumacher WA, JC Fantone, SE Kunkel, RC Webb, BR Lucchesi: The anaphylatoxins C3a and C5a are vasodilators in the canine coronary vasculature in vitro and in vivo. Agents Actions 34 (1991) 345
74. Shin HS, R Snyderman, E Friedman, A Mellors, MMMayer: Chemotactic and anaphylatoxic fragment cleaved from the fifth component of guinea pig complement. Science 162 (1968) 361
75. Sinha D, M Wells, WP Faulk: Immunological studies of human placentae: complement components in preeclamptic chorionic villi. Clin Exp Immunol 56 (1984) 175
76. Soto E, K Richani, R Romero, J Espinoza, T Chaiworapongsa, J Nien, S Edwin, Y Kim, JS Hong, L Goncalves, M Mazor: Increased concentration of the complement split product C5a in acute pyelonephritis during pregnancy. J Matern Fetal Med (2005) (in press)
77. Stevens JH, P O'Hanley, JM Shapiro, FG Mihm, PS Satoh, JA Collins, TA Raffin: Effects of anti-C5a antibodies on the adult respiratory distress syndrome in septic primates. J Clin Invest 77 (1986) 1812
78. Tafuri A, J Alferink, P Moller, GJ Hammerling, B Arnold: T cell awareness of paternal alloantigens during pregnancy. Science 270 (1995) 630
79. Takabayashi T, E Vannier, JF Burke, RG Tompkins, JA Gelfand, BD Clark: Both C3a and C3a (desArg) regulate interleukin-6 synthesis in human peripheral blood mononuclear cells. J Infect Dis 177 (1998) 1622
80. Takabayashi T, E Vannier, BD Clark, NH Margolis, CA Dinarello, JF Burke, JA Gelfand: A new biologic role for C3a and C3a desArg: regulation of TNF-alpha and IL-1 beta synthesis. J Immunol 156 (1996) 3455
81. Takafuji S, K Tadokoro, K Ito, CA Dahinden: Degranulation from human eosinophils stimulated with C3a and C5a. Int Arch Allergy Immunol 104 Suppl 1 (1994) 27
82. Tedesco F, G Narchi, O Radillo, S Meri, S Ferrone, C Betterle: Susceptibility of human trophoblast to killing by human complement and the role of the complement regulatory proteins. J Immunol 151 (1993) 1562
83. Tedesco F, O Radillo, G Candussi, A Nazzaro, TE Mollnes, D Pecorari: Immunohistochemical detection of terminal complement complex and S protein in normal and preeclamptic placentae. Clin Exp Immunol 80 (1990) 236
84. Tichenor JR, LB Bledsoe, MS Opsahl, DS Cunningham: Activation of complement in humans with a first-trimester pregnancy loss. Gynecol Obstet Invest 39 (1995) 79
85. Tsuruta T, T Yamamoto, S Matsubara, S Nagasawa, S Tanase, J Tanaka, K Takagi, T Kambara: Novel function of C4a anaphylatoxin. Release from monocytes of protein which inhibits monocyte chemotaxis. Am J Pathol 142 (1993) 1848
86. Vogt W: Complement activation by myeloperoxidase products released from stimulated human polymorphonuclear leukocytes. Immunobiology 195 (1996) 334
87. Vogt W: Cleavage of the fifth component of complement and generation of a functionally active C5b6-like complex by human leukocyte elastase. Immunobiology 201 (2000) 470
88. Vogt W, B Damerau, Z von, I, R Nolte, D Brunahl: Nonenzymic activation of the fifth component of human complement, by oxygen radicals. Some properties of the activation product, C5b-like C5. Mol Immunol 26 (1989) 1133
89. Volanakis JE: Overview of the Complement System. In: Volanakis JE, MM Frank: The Human Complement System in Health and Disease. Marcel Dekker, Inc., New York 1998
90. Walport MJ: Complement. First of two parts. N Engl J Med 344 (2001) 1058
91. Ward PA: The dark side of C5a in sepsis. Nat Rev Immunol 4 (2004) 133
92. Ward PA, JH Hill: C5 chemotactic fragments produced by an enzyme in lysosomal granules of neutrophils. J Immunol 104 (1970) 535
93. Weiler JM, RW Yurt, DT Fearon, KF Austen: Modulation of the formation of the amplification convertase of complement, C3b, Bb, by native and commercial heparin. J Exp Med 147 (1978) 409
94. Wetsel RA, WP Kolb: Expression of C5a-like biological activities by the fifth component of human complement (C5) upon limited digestion with noncomplement enzymes without release of polypeptide fragments. J Exp Med 157 (1983) 2029
95. Wilson WA: Classification criteria for antiphospholipid syndrome. Rheum Dis Clin North Am 27 (2001) 499
96. Wilson WA, AE Gharavi, T Koike, MD Lockshin, DW Branch, JC Piette, R Brey, R Derksen, EN Harris, GR Hughes, DA Triplett, MA Khamashta: International consen-sus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 42 (1999) 1309
97. Woodruff TM, TV Arumugam, IA Shiels, RC Reid, DP Fairlie, SM Taylor: Protective effects of a potent C5a receptor antagonist on experimental acute limb ischemia-reperfusion in rats. J Surg Res 116 (2004) 81
98. Wymann MP, P Kernen, DA Deranleau, M Baggiolini: Respiratory burst oscillations in human neutrophils and their correlation with fluctuations in apparent cell shape. J Biol Chem 264 (1989) 15829
99. Xu C, D Mao, VM Holers, B Palanca, AM Cheng, H Molina: A critical role for murine complement regulator crry in fetomaternal tolerance. Science 287 (2000) 498
100. Yoon BH, R Romero, M Kim, EC Kim, T Kim, JS Park, JK Jun: Clinical implications of detection of Ureaplasma urealyticum in the amniotic cavity with the polymerase chain reaction. Am J Obstet Gynecol 183 (2000) 1130
101. Youtananukorn V, P Matangkasombut, V Osathanondh: Onset of human maternal cell-mediated immune reaction to placental antigens during the first pregnancy. Clin Exp Immunol 16 (1974) 593